new strategy
growth strategy
existing biosensor technology
new product line
existing products
performance advantages
existing core technology
TRL
Automatic Continuous Blood Glucose
blood glucose levels
yielding high growth
Cost-effective Biosensor
Senzime AB
sales worth
reduced mortality rates
faster recovery rates
need of health care providers
functionality
real commercial customer benefits
portfolio
Swedish medical devices manufacture
leading provider of analyte evaluation systems
investment plan
detailed business
CliniSenzTM system
innovative features
practical way
feasibility report
target market
cost effective
parallel project
ICUs
UK
contacts
projected demand
turnover
prototypes
vision
healthcare professionals
secure funding
clinical trials
experience
deficiencies
vison